Treosulfan medac Uses, Dosage, Side Effects and more
Treosulfan medac is under investigation in Allogeneic Haematopoietic Stem Cell Transplantation. Treosulfan medac has been investigated for the treatment of Lymphoblastic Leukemia, Acute, Childhood.
| Attribute | Details |
|---|---|
| Trade Name | Treosulfan medac |
| Generic | Treosulfan |
| Treosulfan Other Names | DIHYDROXYBUSULFAN, OVASTAT, Treosulfan |
| Type | |
| Formula | C6H14O8S2 |
| Weight | Average: 278.29 Monoisotopic: 278.013009759 |
| Groups | Approved, Investigational |
| Therapeutic Class | |
| Manufacturer | |
| Available Country | Denmark, Russia |
| Last Updated: | January 7, 2025 at 1:49 am |
